Bespoke Extracts (BSPK) Return on Capital Employed (2012 - 2025)
Bespoke Extracts' (BSPK) quarterly Return on Capital Employed came in at 40.24% in Q3 2025, down 3834.0% year-on-year from 1.08% in Q3 2024, and down 41.8% quarter-over-quarter from 69.13% in Q2 2025.
Bespoke Extracts (BSPK) Return on Capital Employed (2012 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Return on Capital Employed across 14 years of filings, most recently posting 40.24% for Q3 2025.
- Return on Capital Employed for Q3 2025 came in at 40.24%, down 3834.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 40.24% (down 3834.0% YoY), and the FY2024 annual result was 130.54%, down 8066.0% from the prior year.
- Return on Capital Employed came in at 40.24% for Q3 2025 at Bespoke Extracts, down from 69.13% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4328.7% in Q2 2021 to a low of 4491.33% in Q4 2021.
- The 5-year median for Return on Capital Employed is 207.99% (2023), against an average of 630.37%.
- Peak annual rise in Return on Capital Employed reached 341464 bps in 2021, while the deepest fall reached 540872 bps in 2021.
- Bespoke Extracts' Return on Capital Employed stood at 4491.33% in 2021, then surged by 119 bps to 844.61% in 2022, then plunged by 75 bps to 207.99% in 2023, then slumped by 38 bps to 129.15% in 2024, then slumped by 69 bps to 40.24% in 2025.
- The last three Return on Capital Employed figures came in at 40.24% (Q3 2025), 69.13% (Q2 2025), and 99.92% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 40.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 40.24% |
| Jun 30, 2025 | 69.13% |
| Mar 31, 2025 | 99.92% |
| Dec 31, 2024 | 129.15% |
| Sep 30, 2024 | 78.57% |
| Jun 30, 2024 | 91.94% |
| Mar 31, 2024 | 134.46% |
| Dec 31, 2023 | 207.99% |
| Sep 30, 2023 | 415.76% |
| Jun 30, 2023 | 999.98% |
| Mar 31, 2023 | 433.79% |
| Dec 31, 2022 | 844.61% |
| Sep 30, 2022 | 2,413.99% |
| Jun 30, 2022 | 545.77% |
| Mar 31, 2022 | 3,066.13% |
| Nov 30, 2021 | -4,491.33% |
| Aug 31, 2021 | -646.01% |
| May 31, 2021 | 4,328.70% |
| Feb 28, 2021 | 3,214.17% |
| Nov 30, 2020 | 917.38% |